Search results
Results from the WOW.Com Content Network
In fact, intrinsic and sometimes adverse effects of a medical treatment are iatrogenic. For example, radiation therapy and chemotherapy—necessarily aggressive for therapeutic effect – frequently produce such iatrogenic effects as hair loss, hemolytic anemia, diabetes insipidus, vomiting, nausea, brain damage, lymphedema, infertility, etc.
Sometimes hair has a tendency to curl after regrowth, resulting in "chemo curls." Severe hair loss occurs most often with drugs such as doxorubicin, daunorubicin, paclitaxel, docetaxel, cyclophosphamide, ifosfamide and etoposide. Permanent thinning or hair loss can result from some standard chemotherapy regimens. [101]
Diagram showing which toner color should be used to counteract red, orange and yellow undertones in bleached hair. Toning is a common practice after bleaching to mask the undesirable red and orange tones of "brassy" hair using a toner dye. Through toning, the yellow hue of fully bleached hair can be removed to achieve platinum blond hair.
Others may develop signs and symptoms after repeated exposures to even [hair bleach]." What can I do to prevent bleach burn on the scalp? No one wants to deal with the unpleasant side effects of a ...
Laser therapy may help FPHL, alopecia areata, and hair loss after chemotherapy. You may need many laser treatments to get the results you’re looking for, though. Platelet-rich plasma therapy.
Chemotherapy-induced nausea and vomiting may require antiemetics (such as ondansetron), and hemorrhagic cystitis is prevented with administration of mesna. Alopecia (hair loss) is common. [5] Neutropenia generally develops in the second week. During this period, many clinicians recommend pegfilgrastim or prophylactic use of ciprofloxacin.
Why Hair Loss after Hysterectomy Surgery Occurs. There are a few reasons why hair loss might occur after a hysterectomy. Below, we unpack the relationship between hysterectomy and hair loss. 1. Stress
The symptoms of PCCI were recognized by researchers in the 1980s, who typically described it as mild cognitive impairment subsequent to successful cancer treatment. [4] Some authors say that it was identified primarily in breast cancer survivor and support groups as affecting a subset of individuals treated with chemotherapy , who attributed it ...